Dow Up 0.35% Nasdaq Down 0.02%

More On NONOF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Novo Nordisk A/S (NONOF)

-Other OTC
46.30 1.15(2.54%) Aug 20, 3:15PM EDT
|Pre-Market : NaN
Prev Close:45.15
Open:44.85
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:44.85 - 46.30
52wk Range:32.50 - 48.90
Volume:50,358
Avg Vol (3m):11,441
Market Cap:121.72B
P/E (ttm):26.64
EPS (ttm):1.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NONOF

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback